Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-20-011163
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-20 17:02:49
Reporting Period:
2020-02-18
Accepted Time:
2020-02-20 17:02:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510487 Principia Biopharma Inc. PRNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413823 Y Christopher Chai C/o Principia Biopharma Inc.
220 E. Grand Avenue
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-18 2,500 $3.00 12,266 No 4 M Direct
Common Stock Disposition 2020-02-18 2,684 $63.86 9,582 No 4 S Direct
Common Stock Disposition 2020-02-18 545 $64.91 9,037 No 4 S Direct
Common Stock Disposition 2020-02-18 1,350 $65.94 7,687 No 4 S Direct
Common Stock Disposition 2020-02-18 605 $67.08 7,082 No 4 S Direct
Common Stock Disposition 2020-02-18 2,240 $68.13 4,842 No 4 S Direct
Common Stock Disposition 2020-02-18 76 $68.52 4,766 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-02-18 2,500 $0.00 2,500 $3.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,157 2023-12-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,302 Indirect See footnote
Footnotes
  1. Includes 1,991 shares and 950 shares acquired under the Employment Stock Purchase Plan on May 15, 2019 and November 15, 2019 respectively.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $63.14 to $63.88 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  4. Represents the weighted average sales price per share. The shares sold at prices ranging from $64.30 to $65.19 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  5. Represents the weighted average sales price per share. The shares sold at prices ranging from $65.41 to $66.33 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  6. Represents the weighted average sales price per share. The shares sold at prices ranging from $66.45 to $67.44 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  7. Represents the weighted average sales price per share. The shares sold at prices ranging from $67.46 to $68.415 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  8. Represents the weighted average sales price per share. The shares sold at prices ranging from $68.48 to $68.66 per share. Upon request by the Commission staff, Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  9. Shares indirectly held by Christopher Chai, as custodian for his children under California Uniform Transfer to Minors Act, of which the Reporting Person is a custodian and may be deemed to share voting and dispositive power over these shares.
  10. The stock option is fully vested and immediately exercisable.